Skip to content

Genetic mutation analysis of the RPS6KA3 gene (tier 2) via whole blood DNA

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific changes (mutations) in the RPS6KA3 gene found in your blood cells. These mutations may be linked to certain genetic conditions or syndromes.

Quick summary

["A genetic test to identify possible inherited conditions through blood analysis."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
53794-4
Short code
RPS6KA3 gene Mut Anl tier2 Bld/T
Synonyms
RPS6KA3 gene Mut Anl tier2 Bld/T
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test examines DNA extracted from your white blood cells to detect mutations in the RPS6KA3 gene. This gene plays a role in cell growth and development, and mutations here could be associated with genetic disorders or increased cancer risk in some cases.

Why Might You Need This Test?

Your healthcare provider may recommend this test if you have a family history of genetic conditions, symptoms suggestive of a genetic disorder, or if you are at higher risk due to certain genetic testing guidelines.

How Is the Sample Collected?

A blood sample is drawn from a vein, usually in your arm. The blood is processed to isolate white blood cells, where the DNA is analyzed for mutations.

What Are the Next Steps?

Results will be reviewed by a genetic counselor or specialist. Depending on findings, you may receive recommendations for further testing, monitoring, or genetic counseling.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: This test helps identify genetic mutations that may influence an individual’s health risks, including potential predispositions to certain cancers or developmental disorders. Early detection can guide preventive measures or management strategies tailored to your genetic profile.

Short name

RPS6KA3 Gene Mutation Test (Tier 2)

Frequently asked questions

What does a positive result mean?
A positive result indicates the presence of a known mutation in the RPS6KA3 gene. This may suggest an increased risk for specific genetic conditions or syndromes, but it does not definitively diagnose a disease. Further evaluation and genetic counseling are recommended to interpret results and discuss next steps.
How long will it take to get results?
Results typically take several weeks to a few months, depending on the complexity of the genetic analysis and the laboratory’s workflow. Your healthcare provider will contact you once results are available.
Is this test covered by insurance?
Coverage for genetic testing varies by insurance plan. It’s best to check with your insurance provider or healthcare provider to confirm if this test is included in your benefits before undergoing the test.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy